Stryker Corporation
SYK · NYSE
- $335.96
- $129.28B
- Open
- —
- —
- $0.00 - $0.00
- $396.86 - $281.00
- —
- —
- 2.03M
About Stryker Corporation
Stryker sells medical technology to hospitals, health systems, surgeons, and other healthcare providers worldwide. Its offerings span MedSurg products, including surgical equipment, hospital furnishings, and emergency-care products, and Orthopaedics and Spine products, including implants and surgical systems; Neurovascular and related technologies extend its portfolio. Revenue comes primarily from selling these devices and associated products through direct and distribution channels, with recurring procedure-driven demand and a large installed base supporting sales. Stryker generated $25.1 billion of revenue and $3.2 billion of net income in fiscal 2025, up from $22.6 billion and $3.0 billion in 2024.
Notable Price Movement
- Aug 3-7$335.963.15%
Stryker fell $10.64, or 3.07%, from $346.60 to $335.96 over the week. The decisive move came after the July 30 earnings release: despite a 9% organic-sales increase, 17.9% adjusted EPS growth, and quarterly EPS and revenue beats, the company narrowed its 2026 guidance, prompting a reported 7.8% after-hours decline and a 6.7% drop to $325.70 on July 31. Shares then recovered 4.8% to $341.20 on August 3, but gave back part of that rebound the next day as investors continued weighing guidance against the cyber-disruption recovery. Broader market moves were mixed, with bond-yield volatility and technology-led gains providing limited support.
